Published in Br J Ophthalmol on April 01, 2007
[Surgical treatments for retinal vein occlusion]. Ophthalmologe (2007) 0.79
An Endovascular Cannulation Needle with an Internal Wire for the Fragmentation of Thrombi in Retinal Vein Occlusion. Transl Vis Sci Technol (2016) 0.75
Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology (2001) 2.61
Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina (1981) 2.05
Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons. Retina (2005) 1.60
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci (2006) 3.18
Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology (2010) 2.21
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review. Br J Ophthalmol (2010) 1.67
Circadian incidence of non-inflammatory retinal artery occlusions. Graefes Arch Clin Exp Ophthalmol (2008) 1.59
Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology (2006) 1.52
Toxic vitreitis outbreak after intravitreal injection. Retina (2010) 1.51
Successful treatment of cystoid macular edema with valdecoxib. J Cataract Refract Surg (2007) 1.50
Bilateral orbital infarction syndrome after bifrontal craniotomy. Arch Ophthalmol (2007) 1.46
Light emitting diode microscope illumination for green fluorescent protein or fluorescein isothiocyanate epifluorescence. Biotechniques (2005) 1.29
Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review. PLoS One (2013) 1.23
Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol (2007) 1.22
Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study. Acta Ophthalmol (2013) 1.16
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review. Curr Opin Ophthalmol (2010) 1.16
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2010) 1.14
Human infection with marten tapeworm. Emerg Infect Dis (2013) 1.13
Posterior vitreous detachment following intravitreal drug injection. Graefes Arch Clin Exp Ophthalmol (2013) 1.00
Corneal surface reconstruction using adult mesenchymal stem cells in experimental limbal stem cell deficiency in rabbits. Acta Ophthalmol (2009) 0.99
Comparison of intraocular tonometry using three different non-invasive tonometers in children. Graefes Arch Clin Exp Ophthalmol (2008) 0.98
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): predictive factors for functional outcome. Study report no. 6. Graefes Arch Clin Exp Ophthalmol (2011) 0.97
Morphological and immunohistochemical changes after corneal cross-linking. Cornea (2013) 0.95
Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion. Am J Ophthalmol (2011) 0.94
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis. Graefes Arch Clin Exp Ophthalmol (2009) 0.94
Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. Graefes Arch Clin Exp Ophthalmol (2005) 0.92
Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice. Exp Eye Res (2007) 0.92
Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol (2004) 0.90
Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina (2010) 0.89
Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy. Acta Ophthalmol (2011) 0.88
Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Ophthalmology (2012) 0.87
Isolated ocular Jarisch-Herxheimer reaction after initiating tuberculostatic therapy in a child. Int Ophthalmol (2014) 0.87
Retinal vascular occlusions: an interdisciplinary challenge. Dtsch Arztebl Int (2008) 0.87
Estrogen receptor expression in meibomian glands and its correlation with age and dry-eye parameters. Graefes Arch Clin Exp Ophthalmol (2003) 0.84
Annular fundus autofluorescence abnormality in a case of macular dystrophy. Doc Ophthalmol (2007) 0.84
Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatment. Eur J Ophthalmol (2010) 0.83
Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective study. Graefes Arch Clin Exp Ophthalmol (2005) 0.83
Arteriovenous dissection in a living human eye: clinicopathologic correlation. Arch Ophthalmol (2005) 0.82
Clinicopathological findings in persistent corneal cowpox infection. JAMA Ophthalmol (2013) 0.82
Syndromic choroideremia: sublocalization of phenotypes associated with Martin-Probst deafness mental retardation syndrome. Invest Ophthalmol Vis Sci (2008) 0.81
In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes. Mol Vis (2012) 0.81
Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice. Graefes Arch Clin Exp Ophthalmol (2005) 0.81
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial. Acta Ophthalmol (2014) 0.80
Combined cataract and glaucoma surgery: endoscope-controlled erbium:YAG-laser goniotomy versus trabeculectomy. Graefes Arch Clin Exp Ophthalmol (2005) 0.80
Epithelial marker expression in Salzmann nodular degeneration shows characteristics of limbal transient amplifying cells and alludes to an involvement of the epithelium in its pathogenesis. Acta Ophthalmol (2010) 0.80
IMPACT OF VITREORETINAL INTERFACE ARCHITECTURE ON SUCCESSFUL VITREOMACULAR TRACTION RESOLUTION IN EYES SCHEDULED FOR INTRAVITREAL OCRIPLASMIN THERAPY. Retina (2016) 0.79
Electrophysiological evaluation of retinal photoreceptor function after repeated bevacizumab injections. Doc Ophthalmol (2008) 0.79
Angiographic findings in arteriovenous dissection (sheathotomy) for decompression of branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2005) 0.78
Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial. Ophthalmologica (2014) 0.77
Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery. J Cataract Refract Surg (2005) 0.77
Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice. Mol Vis (2004) 0.76
Genotypes of JC virus, DNA of cytomegalovirus, and proviral DNA of human immunodeficiency virus in eyes of acquired immunodeficiency syndrome patients. J Neurovirol (2005) 0.76
Analysis of filaggrin mutations and expression in corneal specimens from patients with or without atopic dermatitis. Int Arch Allergy Immunol (2013) 0.76
Histopathological findings after retinal endovascular lysis in central retinal vein occlusion. BMJ Case Rep (2009) 0.75
Franceschetti hereditary recurrent corneal erosion. Am J Ophthalmol (2012) 0.75
Progesterone and estrogen receptors in conjunctival melanoma and nevi. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
Cells of the vitreous body in Behçet's disease. A case report. Adv Exp Med Biol (2003) 0.75
Femtosecond laser-assisted repeat keratoplasty: a case series. Cornea (2011) 0.75
[Laudatio to the 65th birthday of Heinrich Witschel]. Klin Monbl Augenheilkd (2002) 0.75
Congenital ocular malformations (lens subluxation, pupillary displacement, cataract, myopia) and classic galactosaemia associated with Q188R and /or G1391A mutations. Acta Ophthalmol (2010) 0.75